Jaylyn's Position
Science-Backed Investment in Saving Lives
Tens of thousands of Americans die each year waiting for organ transplants. Advances in stem cell biology and tissue engineering offer a path forward — one that requires sustained federal research investment and a clear-eyed scientific policy.
- 1Supports all types of stem cell research to find cures for chronic diseases. Both embryonic and adult stem cell research have shown clinical promise. Restricting research based on non-scientific grounds delays treatments for real patients.
- 2Advocates for developing technology to grow spare human organs for transplants. Lab-grown organs — grown from a patient's own cells — would eliminate rejection risk and dramatically reduce waiting list deaths.
- 3Invests in regenerative medicine to save lives. Regenerative therapies can repair or replace damaged tissue in conditions like heart failure, spinal cord injury, and diabetes, reducing long-term healthcare costs significantly.
- 4Prioritizes scientific progress to solve the organ donor shortage. Over 100,000 Americans are currently on transplant waiting lists. Bioengineered organs and xenotransplantation research could effectively eliminate that backlog within a generation.
